GeneDx Holdings Corp (NAS:WGS)
$ 22.39 -1.63 (-6.79%) Market Cap: 585.51 Mil Enterprise Value: 633.60 Mil PE Ratio: 0 PB Ratio: 2.82 GF Score: 28/100

Q2 2022 Sema4 Holdings Corp Earnings Call Transcript

Aug 15, 2022 / 08:30PM GMT
Release Date Price: $79.2 (-1.23%)
Operator

Good day, and thank you for standing by. Welcome to the Sema4 Second Quarter 2022 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference may be recorded.

I would like to hand the conference over to your speaker today, Joel Kaufman, VP of Finance and Corporate Development. Please go ahead.

Joel Harrison Kaufman
Sema4 Holdings Corp. - VP of Finance & Corporate Development

Thank you, Michelle. Good afternoon, everyone. Thank you all for participating in today's conference call. Joining me from the company today will be Katherine Stueland, Chief Executive Officer; and Kevin Feeley, SVP of Operations and Head of GeneDx. Rich Miao, the company's Interim CFO, is recovering from a medical procedure and will not be able to join the call this afternoon.

Earlier today, Sema4 released financial results for the second quarter ended June 30, 2022. A copy of the press release and our second quarter earnings slide deck are available on the company's website.

Before we begin, I'd like to remind you that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot